» Articles » PMID: 19002853

Expansion of Human Hematopoietic Stem Cells for Transplantation: Trends and Perspectives

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2008 Nov 13
PMID 19002853
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Umbilical cord blood transplantation is clinically limited by its low progenitor cell content. Ex vivo expansion has become an alternative to increase the cell dose available for transplants. Expansion has been evaluated in several ways such as static cultures combining growth factors or mimicking the natural microenvironment using co-culture systems. However, static cultures have a small volume capacity and therefore large-scale expansion has been addressed using bioreactors. These and other biotechnological approaches for the expansion of hematopoietic progenitors and their utility to study several aspects of hematopoietic stem cell biology are discussed here.

Citing Articles

Human Hematopoietic Stem Cells Co-cultured in 3D with Stromal Support to Optimize Lentiviral Vector-mediated Gene Transduction.

Kojabad A, Esmaeili Gouvarchin Ghaleh H, Shahriary A, Farzanehpour M Indian J Hematol Blood Transfus. 2023; 39(2):173-182.

PMID: 37006970 PMC: 10064360. DOI: 10.1007/s12288-022-01576-4.


Cord Blood Plasma and Placental Mesenchymal Stem Cells-Derived Exosomes Increase Ex Vivo Expansion of Human Cord Blood Hematopoietic Stem Cells While Maintaining Their Stemness.

Teleb R, Abdul-Hafez A, Othman A, Ahmed A, Elsaid A, Arif H Cells. 2023; 12(2).

PMID: 36672185 PMC: 9857343. DOI: 10.3390/cells12020250.


3D Scaffolds to Model the Hematopoietic Stem Cell Niche: Applications and Perspectives.

Congrains A, Bianco J, Rosa R, Mancuso R, Saad S Materials (Basel). 2021; 14(3).

PMID: 33530372 PMC: 7865713. DOI: 10.3390/ma14030569.


Synergistic Integration of Mesenchymal Stem Cells and Hydrostatic Pressure in the Expansion and Maintenance of Human Hematopoietic/Progenitor Cells.

Kang Y, Jeong J, Lee T, Lee H, Shin J Stem Cells Int. 2018; 2018:4527929.

PMID: 29681947 PMC: 5848107. DOI: 10.1155/2018/4527929.


Ex-vivo expansion of nonhuman primate CD34 cells by stem cell factor Sall4B.

Shen B, Zhang Y, Dai W, Ma Y, Jiang Y Stem Cell Res Ther. 2016; 7(1):152.

PMID: 27765075 PMC: 5072326. DOI: 10.1186/s13287-016-0413-1.


References
1.
Saulnier N, Di Campli C, Zocco M, Di Gioacchino G, Novi M, Gasbarrini A . From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source?. Eur Rev Med Pharmacol Sci. 2006; 9(6):315-24. View

2.
Mohamed A, Ibrahim A, El-Masry M, Mansour I, Khroshied M, Gouda H . Ex vivo expansion of stem cells: defining optimum conditions using various cytokines. Lab Hematol. 2006; 12(2):86-93. DOI: 10.1532/LH96.05033. View

3.
Yang S, Cai H, Jin H, Tan W . Hematopoietic reconstitution of CD34+ cells grown in static and stirred culture systems in NOD/SCID mice. Biotechnol Lett. 2007; 30(1):61-5. DOI: 10.1007/s10529-007-9517-0. View

4.
Muller-Sieburg C, Sieburg H . The GOD of hematopoietic stem cells: a clonal diversity model of the stem cell compartment. Cell Cycle. 2006; 5(4):394-8. PMC: 1464375. DOI: 10.4161/cc.5.4.2487. View

5.
Zubler R . Ex vivo expansion of hematopoietic stem cells and gene therapy development. Swiss Med Wkly. 2007; 136(49-50):795-9. DOI: 10.4414/smw.2006.11424. View